These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3462303)

  • 61. A new polymorphic determinant on HLA-DQ molecules.
    Shipp MA; Ahmed P; Kannapell CC; Ford JC; McCourt D; Leykam JF; Zacheis M; Bono C; Davie JM; Mustain E
    Hum Immunol; 1986 May; 16(1):24-37. PubMed ID: 2423485
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HLA-DR products are a subset of human Ia antigens.
    Makgoba MW; Fuggle SV; McMichael AJ; Morris PJ
    Nature; 1983 Feb; 301(5900):531-2. PubMed ID: 6185854
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Homogeneity of HLA-DQ,DR phenotypes in lymphocyte subsets of normal individuals.
    Bertrams J; Luboldt W; Dannehl K; Baur MP
    Hum Immunol; 1986 Mar; 15(3):330-5. PubMed ID: 3456999
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An HLA-D region restriction fragment length polymorphism associated with celiac disease.
    Howell MD; Austin RK; Kelleher D; Nepom GT; Kagnoff MF
    J Exp Med; 1986 Jul; 164(1):333-8. PubMed ID: 3014038
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A study of the HLA-D region in patients with classic Kaposi's sarcoma.
    Robbins E; Cohen N; Contu L; Dausset J
    Immunogenetics; 1986; 24(2):115-7. PubMed ID: 3017851
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mouse monoclonal antibody detects a new polymorphic Ia determinant other than HLA-DR antigen: a possible allele of DC-1.
    Maeda H
    Tissue Antigens; 1984 Mar; 23(3):163-70. PubMed ID: 6427972
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Southern analysis of DNA polymorphism among Dw subtypes of DR4.
    Nicklas JA; Noreen HJ; Segall M; Bach FH
    Hum Immunol; 1985 Jun; 13(2):95-103. PubMed ID: 2989225
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HLA-DQ alpha polymorphisms: oligonucleotide probes characterize the contribution of first and second domains to electrophoretic variants.
    Nepom BS; Schwarz DA; Johnston JV; Radka SF
    Hum Immunol; 1989 Aug; 25(4):257-67. PubMed ID: 2768006
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Simplification of two-dimensional gel patterns of HLA class II antigens.
    Rust NA; McMichael AJ
    Tissue Antigens; 1986 Aug; 28(2):72-83. PubMed ID: 3462963
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition.
    Bontrop R; Tilanus M; Mikulski M; van Eggermond M; Termijtelen A; Giphart M
    Immunogenetics; 1986; 23(6):401-5. PubMed ID: 3013763
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNA restriction fragment length polymorphisms characteristic for Dw subtypes of DR2.
    Segall M; Noreen H; Schluender L; Bach FH
    Hum Immunol; 1986 Mar; 15(3):336-43. PubMed ID: 3007406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection of a novel HLA-DQ specificity: serological and immunochemical analyses by a monoclonal antibody.
    Ishikawa N; Kojima H; Nakayama T; Kunikane H; Hawkin S; Fukasawa Y; Ikeda H; Ogasawara K; Kasahara M; Tajima Y
    Immunogenetics; 1987; 26(3):143-9. PubMed ID: 3497872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Typing for HLA class II at the product level.
    Bontrop R; van Miltenburg R; Koning F; Giphart M
    Immunol Lett; 1985; 10(2):115-9. PubMed ID: 3861575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic and functional relationship of the HLA-DR and HLA-DQ antigens.
    Navarrete C; Jaraquemada D; Fainboim L; Karr R; Hui K; Awad J; Bagnara M; Festenstein H
    Immunogenetics; 1985; 21(1):97-101. PubMed ID: 3881342
    [No Abstract]   [Full Text] [Related]  

  • 75. Peptide map comparisons of similar serologically defined HLA-DR antigens isolated from different lymphoblastoid cell lines.
    Goyert SM; Gatti R; Silver J
    Hum Immunol; 1982 Nov; 5(3):205-14. PubMed ID: 6983516
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis.
    Marcadet A; Massart C; Semana G; Fauchet R; Sabouraud O; Merienne M; Dausset J; Cohen D
    Immunogenetics; 1985; 22(1):93-6. PubMed ID: 2991133
    [No Abstract]   [Full Text] [Related]  

  • 77. Loss of polymorphic restriction fragments of class I and class II MHC genes in a malignant melanoma.
    Angelini G; Fossati G; Radice P; Longo A; Piccioli P; Pierotti MA; Ferrara GB; Parmiani G
    J Immunogenet; 1986; 13(2-3):241-6. PubMed ID: 2880915
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Twenty-six DR beta and 16 DQ beta chain IEF variants and their associated HLA-DR, HLA-DQ, and HLA-Dw specificities.
    Rodriguez de Cordoba S; Marshall P; Rubinstein P
    Immunogenetics; 1989; 29(1):49-53. PubMed ID: 2908876
    [No Abstract]   [Full Text] [Related]  

  • 79. Investigation of the genetic regulation in allergic rhinitis.
    Sadanaga Y; Uno M; Kitao Y; Ishikawa T
    Auris Nasus Larynx; 1990; 17(1):23-32. PubMed ID: 2390030
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HLA-DR antigens in multiple sclerosis: two-dimensional gel electrophoresis.
    Sriram S; Stewart GJ; Buhler M; Grumet C; Engleman E
    Neurology; 1985 Feb; 35(2):248-51. PubMed ID: 3855504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.